Andres M Salazar Selected Research

poly ICLC

1/2022	Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas.
2/2021	Hiltonol Cocktail Kills Lung Cancer Cells by Activating Cancer-Suppressors, PKR/OAS, and Restraining the Tumor Microenvironment.
1/2020	Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma.
1/2020	Poly-ICLC, a multi-functional immune modulator for treating cancer.
1/2019	The efficacy of poly-ICLC against Ebola-Zaire virus (EBOV) infection in mice and cynomolgus monkeys.
1/2019	Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial.
1/2018	Enhancing the immune stimulatory effects of cetuximab therapy through TLR3 signalling in Epstein-Barr virus (EBV) positive nasopharyngeal carcinoma.
1/2018	Role of MDA5 and interferon-I in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice.
1/2018	WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia.
1/2017	Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andres M Salazar Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 02/2007
12	Infections 01/2020 - 03/2010
10	Glioma (Gliomas) 01/2022 - 02/2007
7	Brain Neoplasms (Brain Tumor) 12/2020 - 01/2009
7	Melanoma (Melanoma, Malignant) 12/2020 - 02/2007
6	Virus Diseases (Viral Diseases) 03/2017 - 03/2005
5	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2009
3	Injection Site Reaction 01/2019 - 12/2012
2	HIV Infections (HIV Infection) 01/2019 - 10/2012
2	Papillomavirus Infections 12/2015 - 12/2015
2	Foot-and-Mouth Disease 11/2014 - 10/2012
2	Inflammation (Inflammations) 08/2014 - 02/2012
2	Tuberculosis (Tuberculoses) 07/2014 - 05/2010
2	Disease Progression 07/2014 - 10/2010
2	Testicular Neoplasms (Testicular Cancer) 11/2013 - 12/2012
2	Ovarian Neoplasms (Ovarian Cancer) 11/2013 - 12/2012
2	Malaria 03/2013 - 10/2010
2	Viremia 10/2012 - 09/2010
2	Human Influenza (Influenza) 01/2010 - 03/2005
1	Lung Neoplasms (Lung Cancer) 02/2021
1	Diffuse Intrinsic Pontine Glioma 12/2020
1	Prostatic Neoplasms (Prostate Cancer) 11/2020
1	Lymphoma (Lymphomas) 01/2019
1	Neutropenia 01/2019
1	Ebola Hemorrhagic Fever 01/2019
1	Paramyxoviridae Infections (Parainfluenza) 11/2018
1	Leukemia 01/2018
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2018
1	Nasopharyngeal Carcinoma 01/2018
1	Residual Neoplasm 01/2018
1	Chronic Granulomatous Disease 01/2018
1	Aspergillosis 01/2018
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2018
1	Liver Neoplasms (Liver Cancer) 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Stroke (Strokes) 01/2016
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2016
1	Brain Ischemia (Cerebral Ischemia) 01/2016
1	Cryptococcosis 08/2015
1	Brain Injuries (Brain Injury) 01/2015
1	Neuroinflammatory Diseases 01/2015

Drug/Important Bio-Agent (IBA)

32	VaccinesIBA 01/2022 - 03/2005
28	poly ICLCIBA 01/2022 - 03/2005
12	Peptides (Polypeptides)IBA 01/2020 - 02/2007
11	AntigensIBA 02/2017 - 02/2007
11	Poly I-CIBA 01/2017 - 01/2009
10	Carboxymethylcellulose Sodium (Polycell)FDA Link 01/2020 - 02/2007
8	EpitopesIBA 03/2019 - 02/2007
7	Lysine (L-Lysine)FDA Link 01/2020 - 02/2007
5	Immunologic Factors (Immunomodulators)IBA 02/2021 - 03/2005
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2010
5	Cancer VaccinesIBA 01/2020 - 01/2013
5	Protein Subunit VaccinesIBA 03/2019 - 09/2010
4	CytokinesIBA 02/2021 - 01/2013
4	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 01/2009
4	Double-Stranded RNA (RNA, Double Stranded)IBA 11/2020 - 01/2010
4	Monatide (IMS 3015)IBA 01/2020 - 11/2013
4	InterferonsIBA 01/2018 - 08/2005
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 08/2011
4	Antiviral Agents (Antivirals)IBA 10/2012 - 03/2005
3	Pharmaceutical PreparationsIBA 02/2021 - 01/2010
3	Interferon Type IIBA 01/2020 - 07/2014
3	PolylysineIBA 01/2017 - 01/2009
3	Messenger RNA (mRNA)IBA 12/2012 - 09/2010
3	LigandsIBA 09/2012 - 02/2007
2	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2020
2	Pathogen-Associated Molecular Pattern MoleculesIBA 11/2020 - 08/2014
2	ChemokinesIBA 01/2020 - 05/2010
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 06/2013
2	Toll-Like Receptor 3IBA 01/2018 - 01/2016
2	Cetuximab (Erbitux)FDA Link 01/2018 - 06/2013
2	AntibodiesIBA 03/2015 - 10/2012
2	Neoplasm Antigens (Tumor Antigens)IBA 08/2014 - 02/2007
2	Toll-Like Receptor AgonistsIBA 01/2013 - 08/2011
2	Interferon-gamma (Interferon, gamma)IBA 10/2012 - 03/2010
2	Nucleic AcidsIBA 01/2010 - 03/2005
2	OligonucleotidesIBA 01/2010 - 03/2005
1	eIF-2 Kinase (eIF 2 Kinase)IBA 02/2021
1	statticIBA 02/2021
1	AcidsIBA 02/2021
1	2',5'-Oligoadenylate Synthetase (2',5' Oligoadenylate Synthetase)IBA 02/2021
1	Cytochromes c (Cytochrome c)IBA 02/2021
1	Caspase 3 (Caspase-3)IBA 02/2021
1	Caspase 9IBA 02/2021
1	dipinacoline glutamateIBA 12/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Glycoproteins (Glycoprotein)IBA 11/2018
1	Differentiation AntigensIBA 01/2018
1	Therapeutic UsesIBA 03/2017
1	Cell-Penetrating PeptidesIBA 01/2016
1	IFIH1 Interferon-Induced HelicaseIBA 01/2016
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 08/2015
1	tau Proteins (tau Protein)IBA 01/2015

Therapy/Procedure

18	Therapeutics 02/2021 - 09/2010
14	Immunotherapy 01/2022 - 09/2012
4	Radiotherapy 01/2019 - 01/2009
3	Drug Therapy (Chemotherapy) 01/2015 - 06/2013
2	Injections 08/2014 - 09/2010